Inventor · disambiguated record
Robert Segal
Also filed as: SEGAL ROBERT · SEGAL ROBERT M
7 granted patents·15 pending applications·72 citations·filing 1980–2023
83Inventor score
Top patents by PatentIndex Score
22 records- 0185US2024034797A1Increasing responses to checkpoint inhibitors by extracorporeal apheresisIMMUNICOM INC·Filed 2023·Application pending·0 cites
- 0279US8221772B2Pulmonary surfactant formulations and methods for promoting mucus clearanceJOHNSON MARK E·Filed 2007·Granted Jul 17, 2012·5 cites·14 claims
- 0376US2022288294A1System and method for removal of immune inhibitors from biological fluidsIMMUNICOM INC·Filed 2022·Application pending·0 cites
- 0475US11814430B2Increasing responses to checkpoint inhibitors by extracorporeal apheresisIMMUNICOM INC·Filed 2021·Granted Nov 14, 2023·0 cites·11 claims
- 0574US2022054726A1System and method for removal of immune inhibitors from biological fluidsIMMUNICOM INC·Filed 2021·Application pending·0 cites
- 0674US2022041730A1Increasing responses to checkpoint inhibitors by extracorporeal apheresisIMMUNICOM INC·Filed 2021·Application pending·0 cites
- 0774US2022041729A1Increasing responses to checkpoint inhibitors by extracorporeal apheresisIMMUNICOM INC·Filed 2021·Application pending·0 cites
- 0874US2022054727A1System and method for removal of immune inhibitors from biological fluidsIMMUNICOM INC·Filed 2021·Application pending·0 cites
- 0974US2022054725A1System and method for removal of immune inhibitors from biological fluidsIMMUNICOM INC·Filed 2021·Application pending·0 cites
- 1074US2022041732A1Increasing responses to checkpoint inhibitors by extracorporeal apheresisIMMUNICOM INC·Filed 2021·Application pending·0 cites
- 1174US2022041731A1Increasing responses to checkpoint inhibitors by extracorporeal apheresisIMMUNICOM INC·Filed 2021·Application pending·0 cites
- 1273US2022265913A1System and method for removal of immune inhibitors from biological fluidsIMMUNICOM INC·Filed 2022·Application pending·0 cites
- 1373US2022054728A1System and method for removal of immune inhibitors from biological fluidsIMMUNICOM INC·Filed 2021·Application pending·0 cites
- 1472US2021198362A1Increasing responses to checkpoint inhibitors by extracorporeal apheresisIMMUNICOM INC·Filed 2021·Application pending·0 cites
- 1570US11123467B2System and method for removal of immune inhibitors from biological fluidsIMMUNICOM INC·Filed 2020·Granted Sep 21, 2021·0 cites·14 claims
- 1668US2021146029A1System and method for removal of immune inhibitors from biological fluidsIMMUNICOM INC·Filed 2019·Application pending·0 cites
- 1766US6300356B1Method for decreasing QT dispersion or inhibiting the progression of QT dispersion with an angiotensin II receptor antagonistMERCK & CO INC·Filed 1999·Granted Oct 9, 2001·22 cites·17 claims
- 1863US6201002B1Method for reducing mortality with an angiotensin II antagonistMERCK & CO INC·Filed 1998·Granted Mar 13, 2001·35 cites·33 claims
- 1954US2023270691A1Pharmaceutical compositions comprising insoluble active ingredientsADVENT THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2052US2023106684A1Compositions of vitamin a palmitate, processes for their preparation, uses and methods comprising themADVENT THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2145US4319927APortland-type cementsFLINTKOTE CO·Filed 1980·Granted Mar 16, 1982·10 cites·26 claims
- 2240US7541331B2Surfactant treatment regimenDISCOVERY LAB INC·Filed 2006·Granted Jun 2, 2009·0 cites·45 claims
Join the waitlist — get patent alerts
Get an alert when Robert Segal files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →